(Q48891027)

16 February 2018

title

Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. (English)

1 reference

16 February 2018

0 references

1 reference

Timothy K Blackmore

1

1 reference

16 February 2018

Laurens Manning

series ordinal

2

1 reference

16 February 2018

William J Taylor

series ordinal

3

1 reference

16 February 2018

Robert S Wallis

series ordinal

4

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 November 2008

1 reference

16 February 2018

Clinical Infectious Diseases

published in

1 reference

16 February 2018

volume

47

1 reference

16 February 2018

issue

10

1 reference

16 February 2018

page(s)

e83-5

1 reference

16 February 2018

Paradoxical Reaction during Tuberculosis Treatment in HIV-Seronegative Patients

cites work

1 reference

Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review

21 January 2018

1 reference

Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study

21 January 2018

1 reference

Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases

21 January 2018

1 reference

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis

21 January 2018

1 reference

Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda.

21 January 2018

1 reference

Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade

21 January 2018

1 reference

Reconsidering adjuvant immunotherapy for tuberculosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/592695

1 reference

16 February 2018

PubMed ID

18840076

1 reference

16 February 2018